Imbert, Caroline http://orcid.org/0000-0001-7946-6791
Montfort, Anne
Fraisse, Marine
Marcheteau, Elie
Gilhodes, Julia
Martin, Elodie
Bertrand, Florie
Marcellin, Marlène
Burlet-Schiltz, Odile
Peredo, Anne Gonzalez de
Garcia, Virginie http://orcid.org/0000-0002-9761-7036
Carpentier, Stéphane
Tartare-Deckert, Sophie http://orcid.org/0000-0001-8680-5720
Brousset, Pierre
Rochaix, Philippe http://orcid.org/0000-0001-6238-1599
Puisset, Florent
Filleron, Thomas
Meyer, Nicolas
Lamant, Laurence
Levade, Thierry
Ségui, Bruno http://orcid.org/0000-0002-6119-1889
Andrieu-Abadie, Nathalie http://orcid.org/0000-0003-2698-1970
Colacios, Céline http://orcid.org/0000-0002-7509-0675
Funding for this research was provided by:
Fondation ARC pour la Recherche sur le Cancer (TRANS201601250)
Ligue Contre le Cancer (EL2013-5 LEVADE)
Fondation pour la Recherche Médicale (FDT20170437098)
Article History
Received: 10 April 2018
Accepted: 18 December 2019
First Online: 23 January 2020
Competing interests
: N.M. has worked as an investigator and/or consultant and/or speaker for BMS, MSD, Amgen, Roche, GSK, Novartis, Pierre Fabre. B.S. has worked as an investigator, consultant and speaker for BMS. The authors declare that they have no other conflict of interest.